| Description |
1 online resource |
| Series |
Advances in biological psychiatry, 0378-7354 ; v. 26 |
|
Advances in biological psychiatry ; v. 26.
|
| Contents |
History and current definition of treatment resistant schizophrenia / Helio Elkis -- Assessment of therapy resistant schizophrenia / Jean Pierre Lindenmayer -- Neuropsychology of treatment resistant schizophrenia / Neil D. Woodward & Herbert Y. Meltzer -- Genetic studies in treatment resistant schizophrenia / Vincenzo De Luca [and others] -- Neuroimaging of treatment resistant schizophrenia / Joao Guilherme Borgio [and others] -- Duration of untreated psychosis and premorbid functioning : relationship with treatment response and therapy-resistant schizophrenia / William Bobo & Herbert Meltzer -- Disease management: multidimensional approaches to incomplete recovery in psychosis / Tim J. Lambert -- The role of clozapine in the treatment of treatment-resistant schizophrenia / Herbert Meltzer -- Augmenting clozapine response in treatment resistant schizophrenia / Gary Remington -- New therapeutic strategies for resistance to clozapine and treatment resistance schizophrenia / Juliano Santos Souza [and others] -- Eletroconvulsive therapy for treatment- refractory schizophrenia / Worrawat Chanpattana -- Treatment of therapy-resistant auditory verbal hallucinations in schizophrenia patients by repetitive transcranial magnetic stimulation (rTMS) / Martin Jandl & Wolfgang P. Kaschka |
| Summary |
The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment. This volume presents the latest research and recommendations on the definition, causes and therapy of treatment-resistant schizophrenia (TRS). Methods for identification and optimal management of TRS are reviewed. Clozapine and other atypical antipsychotic drugs which are the primary treatment for TRS, as well as non-pharmacologic treatments such as transcranial magnetic stimulation, cognitive behavior therapy and ECT are discussed in depth. Potential causative factors and identifying features such as genetic factors, poor premorbid functioning, longer duration of untreated psychosis, and biological measures such as structural and functional brain abnormalities are also reviewed in depth in the present volume |
| Bibliography |
Includes bibliographical references and indexes |
| Subject |
Schizophrenia -- Chemotherapy.
|
|
Antipsychotic drugs.
|
|
Drug resistance.
|
|
Schizophrenia -- drug therapy
|
|
Antipsychotic Agents
|
|
Antipsychotic Agents -- therapeutic use
|
|
Clozapine -- therapeutic use
|
|
Drug Resistance
|
|
MEDICAL -- Mental Health.
|
|
PSYCHOLOGY -- Mental Health.
|
|
PSYCHOLOGY -- Mental Illness.
|
|
Antipsychotic drugs
|
|
Drug resistance
|
|
Schizophrenia -- Chemotherapy
|
| Form |
Electronic book
|
| Author |
Elkis, Hélio
|
|
Meltzer, Herbert Y
|
| ISBN |
9783805595124 |
|
3805595123 |
|
